Plavix, one of the leading blood thinners, will be reduced by 20 percent for the next three years, together with other flagship products, the health ministry said Monday.
Other leading items that are subject to price cut include Atacand and Xeloda produced by multinational drug manufactures.
The ministry also announced that 100 drugs are eligible for health insurance while 247 items are d...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.